Gregory Hicken, MD
Orthopaedic Surgery · Logan, UTNPI 1225027931
Payments from drug & device makers
Across 82 payments — averaging $158.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$5K
- Smith+Nephew$3K
- Active Medical, LLC$2K
- Stryker$2K
- Zimmer Biomet$698
- Moximed, Inc$276
- plus $299 from 7 others
What the payments were for
- Royalty or licence$3022%
- Speaking & faculty fees$4,00031%
- Travel & lodging$5,31041%
- Food & beverage$2,57120%
- Education$7976%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 9 | $4,647 |
| Smith+Nephew | 22 | $3,062 |
| Active Medical, LLC | 9 | $2,303 |
| Stryker | 21 | $1,696 |
| Zimmer Biomet | 6 | $698 |
| Moximed, Inc | 4 | $276 |
| Heron Therapeutics, Inc. | 2 | $103 |
| Nalu Medical, Inc. | 3 | $57 |
| Siemens Medical Solutions USA, Inc. | 1 | $51 |
| Globus Medical | 2 | $35 |
| Bioventus LLC | 1 | $21 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$2,411
- REAL INTELLIGENCE$2,322
- REDAPT$1,205
- MAKO$784
- ROSA-Knee$607
- Legion$289
- ENTELLUS - XPRESS ENT DILATION SYSTEM$242
- MISHA KNEE SYSTEM, SMALL, LEFT$131
- VISIONAIRE Cutting Guides$114
- Journey II XR$114
- Navio Surgical System$114
How this compares
$12,979 in reported general payments places this provider in the 70th percentile of 221 orthopaedic surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 65 | $1,272 |
| Pregabalin | 40 | $468 |
| Mupirocin | 41 | $328 |
| Hydromorphone Hcl | 48 | $241 |
| Cephalexin | 45 | $212 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $157 |
| Meloxicam | 21 | $133 |
| Tramadol Hcl | 11 | $122 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Logan
- Edwin GobleLogan$1.1M
- Brad LarsonLogan$446K
- Hugh WestMurray$14.2M
- Aaron HofmannSalt Lake City$10.7M
- Armen KhachatryanWest Jordan$3.9M
- Thomas CaltonWashington Terrace$3.5M
- Jeremy GilillandSalt Lake City$3.3M
- Robert TashjianSalt Lake City$3M
- Joshua HickmanBountiful$2.7M
- Jeffrey JacksonSalt Lake City$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.